Citation 13730

JUNG,HJ: PARK,HJ: KIM,RG: SHIN,KM: HA,J: CHOI,JW: KIM,HJ: LEE,JS: LEE,KT:. (2003). IN VIVO ANTI-INFLAMMATORY AND ANTINOCICEPTIVE EFFECTS OF LIRIODENDRIN ISOLATED FROM THE STEM BARK OF ACANTHOPANAX SENTICOSUS.. 69(7)

Citation Details

Title	IN VIVO ANTI-INFLAMMATORY AND ANTINOCICEPTIVE EFFECTS OF LIRIODENDRIN ISOLATED FROM THE STEM BARK OF ACANTHOPANAX SENTICOSUS.
Authors	JUNG,HJ: PARK,HJ: KIM,RG: SHIN,KM: HA,J: CHOI,JW: KIM,HJ: LEE,JS: LEE,KT:
Year	2003
Volume	69
Issue	7

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Eleutherococcus senticosus (ARALIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	VASCULAR PERMEABILITY DECREASED	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANALGESIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	ANALGESIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	TRYPSIN INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OF	LIRIODENDRINCAFFEIC ACID	None
8	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	LIRIODENDRIN	None
9	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIRIODENDRIN	ACTIVE
10	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIRIODENDRIN	ACTIVE
11	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIRIODENDRIN	ACTIVE
12	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIRIODENDRIN	ACTIVE
13	VASCULAR PERMEABILITY DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
14	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
15	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
16	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
17	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SYRINGARESINOL	None
19	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL	ACTIVE
20	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL	ACTIVE
21	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL	ACTIVE
22	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SYRINGARESINOL	ACTIVE
23	Not specified	ISOLATION AND IDENTIFICATION OF	CLEMATISSAPONIN CP-3-B	None
24	Not specified	ISOLATION AND IDENTIFICATION OF	HEDEROSIDE D-2	None
25	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
26	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
27	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
28	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE
29	VASCULAR PERMEABILITY DECREASED	PHARMACOLOGY OF COMPOUND - IN VIVO	LIRIODENDRIN	ACTIVE

Citation 13730

Citation Details

Summary

Organisms and Their Experiments (1)

Eleutherococcus senticosus (ARALIACEAE)

Show SPARQL Queries (1)

Query 1